share_log

NewAmsterdam Pharma | SEC STAFF LETTER: Others

SEC ·  Oct 20, 2022 12:25
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.